CDS 2015:Pozzilli教授:动态血糖监测(CGM)在2型糖尿病管理中的越受欢迎

2015-12-14 MedSci MedSci原创

意大利罗马生物医学院 波齐利(Paolo Pozzilli) 在胰岛素治疗、血糖控制不良的2型糖尿病患者中,新技术的应用及价值一直存在争议。随机试验OpT2mise比较了胰岛素泵持续皮下注射(CSII)和每日多次皮下注射(MDI)对2型糖尿病患者血糖的影响,显示CSII较MDI显著改善患者血糖特征,并且不增加低血糖风险。 近期几项将自我血糖监测(SMBG)整合进糖尿病护理的研究显

意大利罗马生物医学院 波齐利(Paolo Pozzilli)

在胰岛素治疗、血糖控制不良的2型糖尿病患者中,新技术的应用及价值一直存在争议。随机试验OpT2mise比较了胰岛素泵持续皮下注射(CSII)和每日多次皮下注射(MDI)对2型糖尿病患者血糖的影响,显示CSII较MDI显著改善患者血糖特征,并且不增加低血糖风险。

近期几项将自我血糖监测(SMBG)整合进糖尿病护理的研究显示,患者平均血糖水平、血糖变异性、代谢性危险因素、抑郁症/糖尿病相关心理应激和健康行为都有所改善。前瞻性随机试验PRISMA探索强化自我监测血糖管理在非胰岛素治疗的2型糖尿病患者中的价值,是迄今为止有关SMBG 在2 型糖尿病患者中有效性的最大规模研究,其结果确认,在非胰岛素治疗的2型糖尿病患者中,使用结构性SMBG对于指导治疗处方和生活方式干预具有临床价值和整体安全性。

动态血糖监测(CGM)在2型糖尿病管理中的应用由于缺乏基于严格入选受试人群的临床试验以及强有力的循证依据而倍受争议。尽管许多研究通过不同指标对血糖变异性进行评估,CGM测量的平均血糖波动幅度(MAGE)仍被认为是量化血糖波动的最佳指标。报告显示,在胰岛素治疗的2型糖尿病患者中,实时CGM(RT-CGM)可以改善胰岛素波动。在12周内短期、间歇性地使用RT-CGM可有效改善血糖控制,并且不会增加低血糖风险。随访期间RT-CGM相对SMBG的有效性一直持续,并且不增加研究期间患者的药物使用强度。

总之,新技术在2型糖尿病患者管理中显示出有效性,也越来越受欢迎。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2050097, encodeId=e5bc205009e6d, content=<a href='/topic/show?id=4691454e37' target=_blank style='color:#2F92EE;'>#CGM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4547, encryptionId=4691454e37, topicName=CGM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Wed Aug 10 11:03:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690306, encodeId=375116903063d, content=<a href='/topic/show?id=2c33331223f' target=_blank style='color:#2F92EE;'>#动态血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33122, encryptionId=2c33331223f, topicName=动态血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142f29025688, createdName=wgsun, createdTime=Tue May 03 02:03:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931688, encodeId=ceaa193168852, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu Nov 10 12:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48435, encodeId=becb48435e6, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377593, encodeId=811f13e7593e6, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4420, encryptionId=5dfe4420fc, topicName=CDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540174, encodeId=4b9215401e49d, content=<a href='/topic/show?id=da548984604' target=_blank style='color:#2F92EE;'>#血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89846, encryptionId=da548984604, topicName=血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50fd13191418, createdName=jktdtl, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46056, encodeId=a5a746056bb, content=动态监测,提高依从性, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon Dec 14 07:27:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
    2016-08-10 zhishijing
  2. [GetPortalCommentsPageByObjectIdResponse(id=2050097, encodeId=e5bc205009e6d, content=<a href='/topic/show?id=4691454e37' target=_blank style='color:#2F92EE;'>#CGM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4547, encryptionId=4691454e37, topicName=CGM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Wed Aug 10 11:03:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690306, encodeId=375116903063d, content=<a href='/topic/show?id=2c33331223f' target=_blank style='color:#2F92EE;'>#动态血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33122, encryptionId=2c33331223f, topicName=动态血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142f29025688, createdName=wgsun, createdTime=Tue May 03 02:03:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931688, encodeId=ceaa193168852, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu Nov 10 12:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48435, encodeId=becb48435e6, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377593, encodeId=811f13e7593e6, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4420, encryptionId=5dfe4420fc, topicName=CDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540174, encodeId=4b9215401e49d, content=<a href='/topic/show?id=da548984604' target=_blank style='color:#2F92EE;'>#血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89846, encryptionId=da548984604, topicName=血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50fd13191418, createdName=jktdtl, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46056, encodeId=a5a746056bb, content=动态监测,提高依从性, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon Dec 14 07:27:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2050097, encodeId=e5bc205009e6d, content=<a href='/topic/show?id=4691454e37' target=_blank style='color:#2F92EE;'>#CGM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4547, encryptionId=4691454e37, topicName=CGM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Wed Aug 10 11:03:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690306, encodeId=375116903063d, content=<a href='/topic/show?id=2c33331223f' target=_blank style='color:#2F92EE;'>#动态血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33122, encryptionId=2c33331223f, topicName=动态血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142f29025688, createdName=wgsun, createdTime=Tue May 03 02:03:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931688, encodeId=ceaa193168852, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu Nov 10 12:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48435, encodeId=becb48435e6, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377593, encodeId=811f13e7593e6, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4420, encryptionId=5dfe4420fc, topicName=CDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540174, encodeId=4b9215401e49d, content=<a href='/topic/show?id=da548984604' target=_blank style='color:#2F92EE;'>#血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89846, encryptionId=da548984604, topicName=血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50fd13191418, createdName=jktdtl, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46056, encodeId=a5a746056bb, content=动态监测,提高依从性, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon Dec 14 07:27:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2050097, encodeId=e5bc205009e6d, content=<a href='/topic/show?id=4691454e37' target=_blank style='color:#2F92EE;'>#CGM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4547, encryptionId=4691454e37, topicName=CGM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Wed Aug 10 11:03:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690306, encodeId=375116903063d, content=<a href='/topic/show?id=2c33331223f' target=_blank style='color:#2F92EE;'>#动态血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33122, encryptionId=2c33331223f, topicName=动态血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142f29025688, createdName=wgsun, createdTime=Tue May 03 02:03:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931688, encodeId=ceaa193168852, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu Nov 10 12:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48435, encodeId=becb48435e6, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377593, encodeId=811f13e7593e6, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4420, encryptionId=5dfe4420fc, topicName=CDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540174, encodeId=4b9215401e49d, content=<a href='/topic/show?id=da548984604' target=_blank style='color:#2F92EE;'>#血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89846, encryptionId=da548984604, topicName=血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50fd13191418, createdName=jktdtl, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46056, encodeId=a5a746056bb, content=动态监测,提高依从性, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon Dec 14 07:27:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
    2015-12-26 hixiaoluo

    好文章,值得看。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2050097, encodeId=e5bc205009e6d, content=<a href='/topic/show?id=4691454e37' target=_blank style='color:#2F92EE;'>#CGM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4547, encryptionId=4691454e37, topicName=CGM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Wed Aug 10 11:03:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690306, encodeId=375116903063d, content=<a href='/topic/show?id=2c33331223f' target=_blank style='color:#2F92EE;'>#动态血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33122, encryptionId=2c33331223f, topicName=动态血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142f29025688, createdName=wgsun, createdTime=Tue May 03 02:03:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931688, encodeId=ceaa193168852, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu Nov 10 12:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48435, encodeId=becb48435e6, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377593, encodeId=811f13e7593e6, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4420, encryptionId=5dfe4420fc, topicName=CDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540174, encodeId=4b9215401e49d, content=<a href='/topic/show?id=da548984604' target=_blank style='color:#2F92EE;'>#血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89846, encryptionId=da548984604, topicName=血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50fd13191418, createdName=jktdtl, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46056, encodeId=a5a746056bb, content=动态监测,提高依从性, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon Dec 14 07:27:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
    2015-12-15 yangpeizhi
  6. [GetPortalCommentsPageByObjectIdResponse(id=2050097, encodeId=e5bc205009e6d, content=<a href='/topic/show?id=4691454e37' target=_blank style='color:#2F92EE;'>#CGM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4547, encryptionId=4691454e37, topicName=CGM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Wed Aug 10 11:03:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690306, encodeId=375116903063d, content=<a href='/topic/show?id=2c33331223f' target=_blank style='color:#2F92EE;'>#动态血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33122, encryptionId=2c33331223f, topicName=动态血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142f29025688, createdName=wgsun, createdTime=Tue May 03 02:03:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931688, encodeId=ceaa193168852, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu Nov 10 12:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48435, encodeId=becb48435e6, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377593, encodeId=811f13e7593e6, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4420, encryptionId=5dfe4420fc, topicName=CDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540174, encodeId=4b9215401e49d, content=<a href='/topic/show?id=da548984604' target=_blank style='color:#2F92EE;'>#血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89846, encryptionId=da548984604, topicName=血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50fd13191418, createdName=jktdtl, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46056, encodeId=a5a746056bb, content=动态监测,提高依从性, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon Dec 14 07:27:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2050097, encodeId=e5bc205009e6d, content=<a href='/topic/show?id=4691454e37' target=_blank style='color:#2F92EE;'>#CGM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4547, encryptionId=4691454e37, topicName=CGM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d70341, createdName=zhishijing, createdTime=Wed Aug 10 11:03:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690306, encodeId=375116903063d, content=<a href='/topic/show?id=2c33331223f' target=_blank style='color:#2F92EE;'>#动态血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33122, encryptionId=2c33331223f, topicName=动态血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142f29025688, createdName=wgsun, createdTime=Tue May 03 02:03:00 CST 2016, time=2016-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1931688, encodeId=ceaa193168852, content=<a href='/topic/show?id=1a76e6753b9' target=_blank style='color:#2F92EE;'>#糖尿病管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76753, encryptionId=1a76e6753b9, topicName=糖尿病管理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ca4300, createdName=wodejia-dayu, createdTime=Thu Nov 10 12:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48435, encodeId=becb48435e6, content=好文章,值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:05:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377593, encodeId=811f13e7593e6, content=<a href='/topic/show?id=5dfe4420fc' target=_blank style='color:#2F92EE;'>#CDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4420, encryptionId=5dfe4420fc, topicName=CDS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec25412, createdName=yangpeizhi, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540174, encodeId=4b9215401e49d, content=<a href='/topic/show?id=da548984604' target=_blank style='color:#2F92EE;'>#血糖监测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89846, encryptionId=da548984604, topicName=血糖监测)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50fd13191418, createdName=jktdtl, createdTime=Tue Dec 15 15:03:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46056, encodeId=a5a746056bb, content=动态监测,提高依从性, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Mon Dec 14 07:27:00 CST 2015, time=2015-12-14, status=1, ipAttribution=)]
    2015-12-14 老段

    动态监测,提高依从性

    0

相关资讯

CDS 2015 MedSci专访陈莉明教授:《中国血糖监测临床应用指南 2015》新版发布!

  2015年12月9日—12日,由中华医学会、中华医学会糖尿病学分会(CDS)主办,江苏省医学会承办的“中华医学会糖尿病学分会第十九次全国学术会议(CDS 2015)”在苏州国际博览中心举行。 本次会议是2015年国内外糖尿病学术领域的收官之作,是融合本年度美国糖尿病学会(ADA)、欧洲糖尿病研究协会(EASD)、国际糖尿病联盟(IDF)等年度会议精华内容,以及展现中国糖尿病学界基

MedSci参加中华医学会糖尿病学分会第十九次全国学术会议(CDS 2015)

2015年12月9-12日,由中华医学会、中华医学会糖尿病学分会(CDS)主办的“中华医学会糖尿病学分会第十九次全国学术会议(CDS 2015)”在苏州举行。本次会议主题为“创新、规范、普及”,突出基础与临床结合、广度与深度并重、交流与培训并举、学术与公益兼顾等特点。本次会议恰逢中华医学会百年诞辰,会议规模、投稿数量、参会人数均创历史新高,共安排特邀学术报告268个,其中全体大会报告10个,专题研

CDS 2015:协同创新促进发展 规范普及共赢未来

2015年12月9日—12日,由中华医学会、中华医学会糖尿病学分会(CDS)主办,江苏省医学会承办的“中华医学会糖尿病学分会第十九次全国学术会议(CDS 2015)”在苏州国际博览中心举行。本次会议是2015年国内外糖尿病学术领域的收官之作,是融合本年度美国糖尿病学会(ADA)、欧洲糖尿病研究协会(EASD)、国际糖尿病联盟(IDF)等年度会议精华内容,以及展现中国糖尿病学界基础科研最新成果和

CDS 2015:2014年度中国糖尿病领域十大更具影响力研究

2015年12月9-12日,由中华医学会、中华医学会糖尿病学分会(CDS)主办的“中华医学会糖尿病学分会第十九次全国学术会议(CDS 2015)”在苏州举行。在今年的大会上,CDS组委会通过Pubmed检索的271篇由中国学者发表在全球知名期刊在糖尿病领域的相关文章,经过层层选拔,最终评选出10项2014年度最具影响力的研究。获奖名单如下:NO1:SIRT 1 介导GLP-1受体激动剂艾塞那肽对脂

CDS 2015:洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用

北京大学第三医院内分泌科 洪天配教授 二肽基肽酶4(DPP-4)抑制剂与钠-葡萄糖协同转运蛋白-2(SGLT-2)抑制剂是两类新型降糖药物。研究显示,DPP-4酶抑制剂可通过直接作用于肾脏而发挥潜在的肾脏保护作用,而SGLT-2抑制剂则可通过改善肾小球高滤过状态而发挥肾脏保护作用。 本讲座主要从DPP-4酶抑制剂和SGLT-2抑制剂的作用机制、在肾损伤患者中的药代动力学、基础和临床研究相关

项坤三院士获首届CDS科学贡献奖

翁建平教授、纪立农教授、杨文英教授共同启动科学贡献奖 贾伟平教授介绍项坤三院士主要科学成果 多年来,中华医学会糖尿病学分会(CDS)一直致力于通过各种方式促进中国的糖尿病预防、基础和临床研究工作的开展。 CDS第七届委员会成立之后,决定自2014年起设立CDS科学贡献奖。科学贡献奖是CDS的最高学术奖项,旨在对国内的优秀科研成果和科研工作者进行奖励、表彰,并在